Production (Stage)
Avivagen Inc.
VIVXF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -47.04% | 17.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.04% | 17.14% | |||
| Cost of Revenue | -67.95% | 48.85% | |||
| Gross Profit | -2.73% | -19.74% | |||
| SG&A Expenses | -43.70% | 10.60% | |||
| Depreciation & Amortization | -64.60% | -25.17% | |||
| Other Operating Expenses | -- | 8.93% | |||
| Total Operating Expenses | -45.12% | 11.62% | |||
| Operating Income | 44.92% | -11.12% | |||
| Income Before Tax | 23.91% | -7.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.91% | -7.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.91% | -7.36% | |||
| EBIT | 44.92% | -11.12% | |||
| EBITDA | 45.23% | -11.20% | |||
| EPS Basic | 24.37% | -7.21% | |||
| Normalized Basic EPS | 24.32% | -7.25% | |||
| EPS Diluted | 24.37% | -7.21% | |||
| Normalized Diluted EPS | 24.32% | -7.25% | |||
| Average Basic Shares Outstanding | 0.29% | 0.37% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||